Ingredient name requirements
Ingredient name requirements for labelling and packaging of medicines and biologicals.
Latest articles
How to find out what’s in your medicineWant to know what’s in your medicines? The obvious place to start is with the medicine’s label, but there may be more to it.- Dual labelled medicines begin transition to sole medicine ingredient names soonFind out about new transition arrangements for dual labelled ingredient names.
- Therapeutic Goods (Poisons Standard) (COVID-19 Vaccine - Pfizer) (Tozinameran and Famtozinameran) Labelling Exemption 2023This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
Latest consultations
- Consultation: International harmonisation of ingredient names (IHIN) – Dual labelling transition to sole medicine ingredient namesThe TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.
- Consultation: Regulatory options to potentially allow references to the TGA in therapeutic goods advertisingThe TGA is considering regulatory options to allow advertisers, including product sponsors, to make references to the TGA in advertising (including on product labels).
- Consultation: Product Information as a package insert in boxed injectablesPublic consultation on the Product Information (PI) as a package insert in boxed injectable products.